Anavex schedules Sept. 9 investor call to outline clinical development strategy and priorities

• Anavex plans an investor call at 4:00 PM ET on Sept. 9, 2026 to outline clinical development strategy priorities.
• Interim CEO Terrie Kellmeyer will present the company’s forward clinical development planning.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anavex Life Sciences Corp. published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.